Open AccessEffects of aggressive predilatation, sizing, and postdilatation strategy for coronary bioresorbable vascular scaffolds implantation
Author(s) -
Hsiang-Yao Chen,
WeiChieh Huang,
Hao–Wei Teng,
Chuan-Tsai Tsai,
YiLin Tsai,
Ming-Ju Chuang,
Yingying Chen,
TseMin Lu
Publication year - 2022
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000716
Subject(s) - medicine , conventional pci , percutaneous coronary intervention , myocardial infarction , cardiology , debulking , revascularization , mace , fractional flow reserve , timi , adverse effect , target lesion , coronary artery disease , surgery , coronary angiography , cancer , ovarian cancer
The results of the recent Amsterdam Investigator-Initiated Absorb Strategy All-Comers trial showed that the predilatation, sizing, and postdilatation (PSP) technique did not lower the long-term rates of scaffold thrombosis and adverse events. We evaluated the impact of aggressive PSP bioresorbable vascular scaffold (BRS) implantation on the short- and long-term clinical outcomes.